FDA
-
-
-
-
-
-
-
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
-
-
-
-
-
-
-
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
-
-
-
-
-
-
-
GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)
-
-
-
-
-
-
-
GH Research (GHRS) Appoints Villy Valcheva as CEO
-
325,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

